LAM results from the proliferation of typically estrogen receptor alpha (ERa)- and progesterone receptor (PR)-positive smooth muscle-like cells [5–7] with lung metastatic potential [8,9]. The gene discussed is ESR1; the disease is lymphangioleiomyomatosis.